D Aoki

No ORCID on file · 12 papers in corpus · active 1991-2017

Study types

  • article 10
  • other 2

Condition tags

  • endometriosis 11
  • infertility 1
article 2017
Effect of Genistein, Leuprolide Acetate and Dienogest towards Progesterone Receptor, IL-8, MMP-2 Expression of Lesions in a Peritoneal Mice Model of Endometriosis
·doi:10.20902/ijptr.2018.11110

Endometriosis is estrogen-dependent disease that is related to the inflammatory process in the peritoneal cavity. To being activated by pro-inflammatory cytokines, endometriosis is also influenced by the response of progesterone receptors. …

other 2014
Development of pro-apoptotic peptides as potential therapy for peritoneal endometriosis
Nature communications ·doi:10.1038/ncomms5478

Endometriosis is a common gynaecological disease associated with pelvic pain and infertility. Current treatments include oral contraceptives combined with nonsteroidal anti-inflammatory drugs or surgery to remove lesions, all of which provi…

article 2011
Biological significance of plasminogen activator inhibitor-1 expression in ovarian clear cell adenocarcinoma.
European journal of gynaecological oncology

PURPOSE: Ovarian clear cell adenocarcinoma (OCCA) has been reported to display different characteristics from other histological types of epithelial ovarian cancer, and especially differs from serous adenocarcinoma. We investigated plasmino…

article 2005
Efficient screening for ovarian cancers using a combination of tumor markers CA602 and CA546
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society ·doi:10.1111/j.1048-891x.2005.15004.x
article 2001
[The biological property of ovarian cancers is affected by endometriosis--with special reference to ovarian clear cell adenocarcinoma].
Nihon rinsho. Japanese journal of clinical medicine
article 1999
Prognosis of Japanese Patients with Ovarian Clear Cell Carcinoma Associated with Pelvic Endometriosis: Clinicopathologic Evaluation
Gynecologic oncology ·doi:10.1006/gyno.1998.5284
article 1998
Clinical characteristics of a newly developed ovarian tumour marker, galactosyltransferase associated with tumour (GAT)
European journal of cancer (Oxford, England : 1990) ·doi:10.1016/s0959-8049(97)10079-x
article 1998
Effects of dienogest, a synthetic steroid, on experimental endometriosis in rats
European journal of endocrinology ·doi:10.1530/eje.0.1380216

OBJECTIVE: Dienogest, a synthetic steroid with progestational activity, is used as a component of oral contraceptives and is currently being evaluated clinically for the treatment of endometriosis. The present study was conducted to confirm…

article 1997
Animal studies on the endocrinological profile of dienogest, a novel synthetic steroid.
Drugs under experimental and clinical research

Dienogest is an orally active synthetic steroid that is used for contraception and is currently being studied for the possible treatment of endometriosis. Earlier we demonstrated that dienogest had therapeutic effects on experimental endome…

article 1997
Dienogest, a novel synthetic steroid, overcomes hormone-dependent cancer in a different manner than progestins
Cancer ·doi:10.1002/(sici)1097-0142(19970101)79:1<169::aid-cncr24>3.0.co;2-1

BACKGROUND: Dienogest is a synthetic progestational steroid that is used for contraception. It is being studied for the treatment of endometriosis, but its anticancer activity remains unknown. The authors investigated the anticancer effect …

article 1993
[Preclinical and clinical studies on a tumor marker, galactosyltransferase associated with tumor (GAT), in ovarian cancer (second report)--clinical significance of GAT and comparison with other tumor markers].
Gan to kagaku ryoho. Cancer & chemotherapy

Galactosyltransferase Associated with Tumor (GAT) was clinically studied in cases of ovarian cancer. When two cut-off levels of GAT were compared, the cut-off level of 16 U/ml (which corresponds to mean + 2SD among healthy females) was foun…

other 1991
A new CA125-like antigen (CA602) recognized by two monoclonal antibodies against a newly established ovarian clear cell carcinoma cell line (RMG-II)
Japanese journal of cancer research : Gann ·doi:10.1111/j.1349-7006.1991.tb02713.x

A cell line designated RMG-II was established from the ascites of a patient with ovarian clear cell carcinoma. The chromosomal analysis revealed aneuploidy with a hypertetraploid modal number and 8 marker chromosomes. Radioimmunoassay and i…